Please note: Our next Awareness Night is Wed. Nov. 22, not Nov. 29 as has appeared in some places.

Active Surveillance

Active Surveillance

September 3, 2017

Predicting outcomes on active surveillance for intermediate-risk patients Read the article here. Active Surveillance for Intermediate-risk Prostate Cancer Challenged Read the article here. Active Surveillance versus Watchful Waiting Read the article here. Surgery isn’t necessarily best for prostate cancer, according to study led by Minneapolis VA Read the article here.

Read the article or watch the video →

Video: Active Surveillance: Protecting Patients from Harm – Dr. Laurence Klotz

August 2, 2017

From a conference in May 2017, a comprehensive overview of active surveillance by one of the experts in the field. View video.

Read the article or watch the video →

Active Surveillance in Men under 60

July 2, 2017

Younger age at diagnosis of low-risk prostate cancer was independently associated with decreased risk of disease progression in men managed with active surveillance, researchers reported. Read the article here. Active surveillance is a reasonable option for carefully selected men under 60 with low-risk prostate cancer. However, patients must be surveyed closely and understand the significant […]

Read the article or watch the video →

Active Surveillance for Prostate Cancer: How to Do It Right

July 2, 2017

Active surveillance should be offered to patients with a low risk of cancer progression, including those with a life expectancy of more than 10 years, clinical stage T1/2a disease, a PSA level < 15 ng/mL, and biopsy Gleason score of ≤ 6. Read the article here.

Read the article or watch the video →

15-year metastasis-free survival in men on active surveillance in The Netherlands

May 7, 2017

According to new data reported at the annual meeting of the European Association of Urology in London, active surveillance of men diagnosed with low-risk prostate cancer was not associated with an elevated risk for metastatic disease at 15 years of follow-up. Read the article here.

Read the article or watch the video →

What influences opting out of active surveillance?

April 9, 2017

A man’s race/ethnicity might influence decision-making regarding opting for active treatment as well as undergoing serial biopsies during active surveillance, according to a recent study. Read the article here.

Read the article or watch the video →

Prostate Cancer: New Directions With Active Surveillance

January 2, 2017

Howard Wolinsky, a journalist based in the Chicago area, was diagnosed with early prostate cancer in 2010. After over 5 years of active surveillance, he describes his continuing quest to make the best — and most informed — decision about his care. Read the article here.

Read the article or watch the video →

Prostate Imaging Reporting and Data System score of four or more: active surveillance no more

January 2, 2017

The introduction of multiparametric MRI (mpMRI) has improved the diagnosis and risk stratification of intermediate and high-risk prostate cancer. In addition to diagnosis, mpMRI has increasingly become a useful tool for monitoring the prostate cancer risk of patients on active surveillance (AS) programmes. Long-term data indicates that there is no oncological benefit for AS programmes […]

Read the article or watch the video →

Preventing Overtreatment of Prostate Cancer: New Model Identifies Ideal Patients for Active Surveillance

October 23, 2016

A new care model for patients with low-risk prostate cancer may help prevent disease overtreatment. This evidence-based approach uses best practices to select patients to avoid disease overtreatment. Results from a 3-year study recently published in Urology indicate that active surveillance (AS) rates nearly doubled after this model was adopted. Read the article here.

Read the article or watch the video →

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

September 21, 2016

This New England Journal of Medicine article gives  the results of a randomized trial of 3 possible prostate cancer treatments.  It is rather long and academic, but shows similar results for the 3 options. Read the article here.

Read the article or watch the video →